Valeant Pharmaceuticals International, Inc. (VRX) Receives Average...
Valeant Pharmaceuticals International, Inc. has earned a consensus recommendation of "Hold" from the twenty-four research firms that are covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation, six have issued a buy recommendation and one has issued a strong buy recommendation on the company.
from Biotech News
0 Comments